Endocrine and Metabolic Conditions Flashcards

A driver holds a Federal Diabetes Exemption and reports one episode of nocturnal hypoglycemia in the past year that required assistance. What must the NRCME examiner do?

Answer: Report the episode and defer renewal of the exemption pending FMCSA review

Any severe hypoglycemic episode requiring third-party assistance must be reported to FMCSA and may jeopardize exemption renewal.

Which finding on a DOT physical would MOST likely prompt the NRCME examiner to screen for undiagnosed diabetes in an otherwise asymptomatic driver?

Answer: Urinalysis showing glucosuria

Glucosuria on urinalysis is a classic indicator of hyperglycemia and should prompt further evaluation for diabetes.

A driver with well-controlled Graves' disease (hyperthyroidism) treated with methimazole has a resting heart rate of 102 bpm and mild tremor. What should the NRCME examiner do?

Answer: Disqualify until thyroid function is normalized and symptoms resolve

Active hyperthyroid symptoms including tachycardia and tremor indicate inadequate control, which poses a safety risk and warrants disqualification until stabilized.

Under FMCSA guidelines, a driver using an oral hypoglycemic agent (e.g., metformin) with no insulin use and an A1c of 6.8% should be:

Answer: Certified under standard medical criteria if no hypoglycemia risk or other disqualifying conditions

Oral hypoglycemic agents not causing hypoglycemia do not trigger the insulin exemption requirement, and well-controlled diabetes on such therapy is certifiable.

A driver with primary adrenal insufficiency (Addison's disease) on stable hydrocortisone and fludrocortisone replacement presents with normal electrolytes and no symptoms. Which concern is MOST important for the NRCME examiner?

Answer: Risk of adrenal crisis during sudden stress or illness while operating a CMV

Adrenal crisis—potentially causing sudden incapacitation—is the primary safety concern for CMV drivers with adrenal insufficiency.

A driver with chronic kidney disease stage 3 secondary to diabetic nephropathy has an eGFR of 42 mL/min/1.73m². He is not on dialysis and reports no fatigue or cognitive symptoms. What is the most appropriate NRCME certification decision?

Answer: Certify if diabetes and blood pressure are adequately controlled and no uremic symptoms are present

CKD stage 3 without uremic symptoms or functional impairment does not automatically disqualify a driver; assessment focuses on control of underlying conditions.

A CMV driver reports taking semaglutide (GLP-1 agonist) for type 2 diabetes. He does not use insulin. He reports no hypoglycemic episodes. Which statement regarding certification is correct?

Answer: Driver may be certified under standard criteria if diabetes is controlled and no other disqualifying conditions exist

GLP-1 agonists are not insulin and do not carry significant hypoglycemia risk when used without insulin; standard certification criteria apply.